FONR
Fonar Corporation
NASDAQ: FONR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$18.93
-0.05% today
Updated 2026-04-30
Market cap
$118.64M
P/E ratio
16.37
P/S ratio
1.12x
EPS (TTM)
$1.15
Dividend yield
—
52W range
$12 – $19
Volume
0.1M
Fonar Corporation (FONR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
7.13%
Operating margin
11.70%
ROE
6.01%
ROA
3.16%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $33.08M | $-29.96M | 18.52% | -89.87% | -90.59% |
| 2007 | $33.21M | $-25.54M | 19.73% | -76.64% | -76.90% |
| 2008 | $35.57M | $-13.51M | 30.01% | -71.56% | -37.98% |
| 2009 | $39.72M | $1.12M | 44.31% | -1.77% | 2.82% |
| 2010 | $31.82M | $-3.01M | 41.47% | -8.11% | -9.47% |
| 2011 | $33.14M | $3.16M | 44.23% | 11.44% | 9.54% |
| 2012 | $39.44M | $5.78M | 46.26% | 18.27% | 14.64% |
| 2013 | $49.14M | $8.68M | 46.84% | 15.33% | 17.66% |
| 2014 | $68.51M | $10.40M | 45.63% | 17.96% | 15.18% |
| 2015 | $69.05M | $12.91M | 44.38% | 18.68% | 18.70% |
| 2016 | $73.37M | $15.72M | 47.02% | 19.57% | 21.43% |
| 2017 | $78.04M | $19.62M | 51.24% | 24.47% | 25.14% |
| 2018 | $81.52M | $21.23M | 48.54% | 24.15% | 26.04% |
| 2019 | $87.19M | $15.32M | 49.55% | 25.39% | 17.57% |
| 2020 | $85.69M | $8.24M | 49.47% | 15.93% | 9.62% |
| 2021 | $89.93M | $10.21M | 48.34% | 19.01% | 11.35% |
| 2022 | $97.59M | $12.44M | 48.17% | 22.55% | 12.75% |
| 2023 | $98.65M | $9.38M | 46.38% | 14.99% | 9.50% |
| 2024 | $102.88M | $10.57M | 43.87% | 16.07% | 10.27% |
| 2025 | $104.35M | $8.33M | 81.67% | 11.12% | 7.99% |